NL300365I1 - Recombinante influenzavirussen voor vaccins en gentherapie - Google Patents

Recombinante influenzavirussen voor vaccins en gentherapie

Info

Publication number: NL300365I1
Authority: NL; Netherlands
Prior art keywords: vaccines; gene therapy; influenza viruses; recombinant influenza; viruses
Prior art date: 1999-04-06

Application number

NL300365C

Other languages

English (en)

Other versions

NL300365I2 (nl

Original Assignee

Wisconsin Alumni Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-06

Filing date

2008-11-13

Publication date

2009-01-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26826080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300365(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-11-13 Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found

2009-01-05 Publication of NL300365I1 publication Critical patent/NL300365I1/nl

2017-08-03 Publication of NL300365I2 publication Critical patent/NL300365I2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Plant Pathology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NL300365C 1999-04-06 2008-11-13 Geïnactiveerd split influenzavirus van influenzastam A/Indonesia/05/2005 (H5N1) (PR8-IBCDC-RG2), desgewenst van een influenzastam die verondersteld wordt nauwe gelijkenis te vertonen met een influenzastam die verantwoordelijk zal zijn voor een pandemieNIBRG-14 NL300365I2 (nl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US12791299P	1999-04-06	1999-04-06
US13283999P	1999-05-06	1999-05-06
PCT/US2000/009021 WO2000060050A2 (en)	1999-04-06	2000-04-05	Recombinant influenza viruses for vaccines and gene therapy

Publications (2)

Publication Number	Publication Date
NL300365I1 true NL300365I1 (nl)	2009-01-05
NL300365I2 NL300365I2 (nl)	2017-08-03

Family

ID=26826080

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NL300364C NL300364I2 (nl)	1999-04-06	2008-11-13	Geïnactiveerd split influenzavirus van influenzastam A/California/7/2009 (H1N1) (X-179A), desgewenst van een pandemische influenzastam in een officieel verklaarde pandemische situatie
NL300365C NL300365I2 (nl)	1999-04-06	2008-11-13	Geïnactiveerd split influenzavirus van influenzastam A/Indonesia/05/2005 (H5N1) (PR8-IBCDC-RG2), desgewenst van een influenzastam die verondersteld wordt nauwe gelijkenis te vertonen met een influenzastam die verantwoordelijk zal zijn voor een pandemieNIBRG-14

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NL300364C NL300364I2 (nl)	1999-04-06	2008-11-13	Geïnactiveerd split influenzavirus van influenzastam A/California/7/2009 (H1N1) (X-179A), desgewenst van een pandemische influenzastam in een officieel verklaarde pandemische situatie

Country Status (19)

Country	Link
EP (4)	EP2910629B1 (nl)
JP (3)	JP5543048B2 (nl)
KR (1)	KR100702275B1 (nl)
CN (2)	CN1350578B (nl)
AT (2)	ATE368729T1 (nl)
AU (1)	AU4073300A (nl)
BR (1)	BRPI0009580B8 (nl)
CA (2)	CA2365526C (nl)
CY (2)	CY1108520T1 (nl)
DE (6)	DE122008000058I1 (nl)
DK (3)	DK1820853T3 (nl)
ES (3)	ES2373405T3 (nl)
FR (1)	FR11C0027I2 (nl)
HK (1)	HK1214298A1 (nl)
IL (2)	IL145702A0 (nl)
MX (1)	MXPA01010082A (nl)
NL (2)	NL300364I2 (nl)
PT (2)	PT1820853E (nl)
WO (1)	WO2000060050A2 (nl)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6544785B1 (en)	1998-09-14	2003-04-08	Mount Sinai School Of Medicine Of New York University	Helper-free rescue of recombinant negative strand RNA viruses
US8715940B2 (en)	1999-04-06	2014-05-06	Wisconsin Alumni Research Foundation	Method of making recombinant influenza virus
PT1820853E (pt) *	1999-04-06	2012-01-03	Wisconsin Alumni Res Found	Vírus recombinante da gripe para vacinas e terapia genética
GB9916794D0 (en) *	1999-07-16	1999-09-22	Isis Innovation	In vitro virus reconstitution
EP1194580B2 (en) *	1999-07-14	2010-08-25	Mount Sinai School of Medicine of New York University	In vitro reconstitution of segmented negative-strand rna viruses
CN100489107C (zh)	2000-04-28	2009-05-20	圣朱德儿童研究医院	用于产生感染性流感病毒的dna转染系统
EP1862550A1 (en) *	2000-06-23	2007-12-05	Wyeth Holdings Corporation	Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
BRPI0111830B8 (pt)	2000-06-23	2021-05-25	American Cyanamid Co	método de produção de partículas semelhantes ao vírus da influenza (vlps), vlps da influenza, vlps quiméricas, composições imunogênica e farmacêutica, e, usos de vlps da influenza e de vlps quiméricas
US7211378B2 (en)	2002-01-31	2007-05-01	Wisconsin Alumni Research Foundation	Filovirus vectors and noninfectious filovirus-based particles
EP3009507B1 (en)	2002-02-13	2020-06-24	Wisconsin Alumini Research Foundation	Signal for packaging of influenza virus vectors
CN1678345A (zh)	2002-04-26	2005-10-05	米迪缪尼疫苗股份有限公司	制备流感病毒的多质粒系统
US7465456B2 (en)	2002-04-26	2008-12-16	Medimmune, Llc	Multi plasmid system for the production of influenza virus
AU2004249133B2 (en) *	2003-05-28	2009-05-28	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses for vaccines and gene therapy
US7566458B2 (en)	2003-06-16	2009-07-28	Medimmune, Llc	Influenza hemagglutinin and neuraminidase variants
ATE469972T1 (de)	2003-12-23	2010-06-15	Medimmune Llc	Multiplasmid-system zur erzeugung des grippevirus
FR2866031B1 (fr) *	2004-02-11	2012-10-19	David Francois Joseph Millet	Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale
DE202005022108U1 (de)	2004-03-09	2013-11-12	Novartis Vaccines And Diagnostics, Inc.	Influenza-Virus-Impfstoffe
EP1766059B1 (en)	2004-05-25	2012-07-11	MedImmune Vaccines, Inc.	Influenza hemagglutinin and neuraminidase variants
EP1814990A2 (en)	2004-11-19	2007-08-08	Wisconsin Alumni Research Foundation	Recombinant influenza vectors with tandem transcription units
CA2593036A1 (en)	2004-12-08	2006-06-15	Medimmune Vaccines, Inc.	Methods of producing influenza vaccine compositions
DK1831357T3 (da)	2004-12-24	2012-12-10	Abbott Biologicals Bv	Genvinding af influenzavirus
ES2527503T3 (es)	2005-03-08	2015-01-26	Medimmune, Llc	Virus influenza reordenantes
US11707520B2 (en)	2005-11-03	2023-07-25	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
BRPI0618254A2 (pt)	2005-11-04	2011-08-23	Novartis Vaccines & Diagnostic	emulsões com agente tensoativo de fase aquosa livre para fornecer adjuvante às vacinas contra influenza dividido
CN102755645A (zh)	2005-11-04	2012-10-31	诺华疫苗和诊断有限公司	佐剂配制的包含细胞因子诱导剂的流感疫苗
PL1945252T3 (pl)	2005-11-04	2013-11-29	Seqirus Uk Ltd	Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
PL1951299T3 (pl)	2005-11-04	2012-07-31	Novartis Ag	Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
EP2251034B1 (en)	2005-12-02	2018-02-14	Icahn School of Medicine at Mount Sinai	Chimeric newcastle disease viruses presenting non-native surface proteins and uses thereof
KR20080089663A (ko)	2006-01-27	2008-10-07	노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게	적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
JP2009534303A (ja)	2006-03-24	2009-09-24	ノバルティスヴァクシンズアンドダイアグノスティクスゲーエムベーハーアンドカンパニーカーゲー	冷蔵しないインフルエンザワクチンの保存
JP2009532352A (ja)	2006-03-31	2009-09-10	ダブリュエーアールエフ−ウィスコンシンアラムナイリサーチファウンデーション	ワクチンのための高力価組み換えインフルエンザ・ウィルス
US20090017444A1 (en) *	2006-06-09	2009-01-15	Wisconsin Alumni Research Foundation	Screening method for modulators of viral transcription or replication
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
US7601356B2 (en)	2006-07-21	2009-10-13	Medimmune, Llc	Methods and compositions for increasing replication capacity of an influenza virus
AU2007286161B2 (en)	2006-08-09	2013-05-02	Medimmune, Llc	Influenza hemagglutinin and neuraminidase variants
WO2008032219A2 (en)	2006-09-11	2008-03-20	Novartis Ag	Making influenza virus vaccines without using eggs
CN101553252A (zh)	2006-12-06	2009-10-07	诺华有限公司	包含来自于四株流感病毒的抗原的疫苗
US8597661B2 (en)	2007-05-04	2013-12-03	Wisconsin Alumni Research Foundation	Neuraminidase-deficient live influenza vaccines
US9474798B2 (en)	2007-06-18	2016-10-25	Wisconsin Alumni Research Foundation	Influenza M2 protein mutant viruses as live influenza attenuated vaccines
EP2069484B1 (en)	2007-06-18	2014-08-13	MedImmune, LLC	Influenza B viruses having alterations in the hemaglutinin polypeptide
EP2045323A1 (en) *	2007-10-05	2009-04-08	Avir Green Hills Biotechnology Research Development Trade Ag	Linear expression constructs for production of influenza virus particles
HRP20120790T1 (hr)	2007-06-27	2013-01-31	Novartis Ag	Cjepiva protiv influence sa niskom koliäśinom aditiva
CN101497877B (zh) *	2008-01-28	2012-09-05	河北摩百生物科技有限公司	流感全病毒减活疫苗重组体、其构建方法及应用
ES2535101T3 (es)	2008-03-18	2015-05-05	Novartis Ag	Mejoras en la preparación de antígenos en vacuna de virus de la gripe
US8591914B2 (en)	2008-07-11	2013-11-26	Medimmune, Llc	Influenza hemagglutinin and neuraminidase variants
WO2010021289A1 (ja)	2008-08-18	2010-02-25	学校法人北里研究所	トリインフルエンザウイルス抗原及び経口投与で有効な粘膜アジュバントを併用したトリインフルエンザワクチンの追加免疫方法
EP2233568A1 (en)	2009-03-19	2010-09-29	Avir Green Hills Biotechnology Research Development Trade AG	Novel method for generation of RNA virus
WO2010092477A1 (en)	2009-02-10	2010-08-19	Novartis Ag	Influenza vaccines with increased amounts of h3 antigen
EP2396032B1 (en)	2009-02-10	2016-09-28	Seqirus UK Limited	Influenza vaccines with reduced amounts of squalene
WO2010092476A1 (en)	2009-02-10	2010-08-19	Novartis Ag	Influenza vaccine regimens for pandemic-associated strains
SG2014010185A (en)	2009-02-12	2014-06-27	Medimmune Llc	Influenza hemagglutinin and neuraminidase variants
CA2763816A1 (en)	2009-04-27	2010-11-04	Novartis Ag	Adjuvanted vaccines for protecting against influenza
CA2773637A1 (en)	2009-09-10	2011-03-17	Novartis Ag	Combination vaccines against respiratory tract diseases
ES2813347T3 (es)	2009-10-26	2021-03-23	Wisconsin Alumni Res Found	Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero
US10130697B2 (en)	2010-03-23	2018-11-20	Wisconsin Alumni Research Foundation (Warf)	Vaccines comprising mutant attenuated influenza viruses
EP2576773A2 (en)	2010-06-02	2013-04-10	Avir Green Hills Biotechnology Research Development Trade AG	Methods and helper viruses for the generation of rna virus
CN102220293B (zh) *	2011-05-26	2012-12-19	中国农业科学院上海兽医研究所	犬流感重组病毒及其制备方法和应用
ES2655051T3 (es)	2011-08-26	2018-02-16	Wisconsin Alumni Research Foundation	Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
EP2751260A2 (en)	2011-09-02	2014-07-09	Westfälische Wilhelms-Universität Münster	Live attenuated influenza virus
EP2768528A1 (en)	2011-10-20	2014-08-27	Novartis AG	Adjuvanted influenza b virus vaccines for pediatric priming
GB201218195D0 (en)	2012-10-10	2012-11-21	Istituto Zooprofilattico Sperimentale Delle Venezie	Composition
AU2014290203B2 (en)	2013-07-15	2020-12-24	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
US10053671B2 (en)	2014-06-20	2018-08-21	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to additional genes in influenza viruses
CN104450695B (zh) *	2014-11-26	2017-08-25	扬州大学	A型流感病毒基因pcr扩增引物及其快速克隆方法
US10633422B2 (en)	2015-06-01	2020-04-28	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
HK1246183A1 (zh) *	2015-06-10	2018-09-07	Hookipa Biotech Gmbh	Hpv疫苗
AU2016281904B2 (en)	2015-06-26	2022-08-11	Seqirus UK Limited	Antigenically matched influenza vaccines
WO2017007839A1 (en)	2015-07-06	2017-01-12	Wisconsin Alumni Research Foundation (Warf)	Improved influenza virus replication for vaccine development
WO2017005880A1 (en)	2015-07-07	2017-01-12	Seqirus UK Limited	Influenza potency assays
EP3341018A1 (en)	2015-08-28	2018-07-04	Wisconsin Alumni Research Foundation	Generation of infectious influenza viruses from virus-like particles
AU2017221444B2 (en)	2016-02-19	2021-07-29	Wisconsin Alumni Research Foundation (Warf)	Improved influenza B virus replication for vaccine development
CN111246846B (zh) *	2017-08-28	2022-06-17	威斯康星校友研究基金会	用于递送核糖核蛋白的纳米胶囊
US11197926B2 (en)	2017-10-25	2021-12-14	Wisconsin Alumni Research Foundation (Warf)	Recombinant influenza viruses with stabilized HA for replication in eggs
CN107964035B (zh) *	2017-12-06	2020-07-24	中国科学院微生物研究所	一种用于流感病毒的有限复制型黏膜免疫疫苗
US12343390B2 (en)	2018-08-07	2025-07-01	Wisconsin Alumni Research Foundation (Warf)	Recombinant biologically contained filovirus vaccine
US11389523B2 (en)	2018-08-20	2022-07-19	Wisconsin Alumni Research Foundation (Warf)	Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
CN109097341B (zh) *	2018-08-28	2021-09-24	青岛农业大学	一种同时表达ha和hef的复制缺陷型重组流感病毒
EP3914295A2 (en)	2019-01-23	2021-12-01	Yoshihiro Kawaoka	Mutations that confer genetic stability to additional genes in influenza viruses
CN113874496A (zh)	2019-02-08	2021-12-31	威斯康星校友研究基金会(Warf)	人源化细胞系
WO2020223699A1 (en)	2019-05-01	2020-11-05	Wisconsin Alumni Research Foundation (Warf)	Improved influenza virus replication for vaccine development
JP7627911B2 (ja)	2019-08-27	2025-02-07	ウィスコンシンアルムニリサーチファンデイション	卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
WO2021150874A1 (en)	2020-01-24	2021-07-29	Wisconsin Alumni Research Foundation (Warf)	Recombinant influenza viruses with stabilized na
WO2021195410A1 (en)	2020-03-25	2021-09-30	Wisconsin Alumni Research Foundation (Warf)	Recombinant multivalent influenza viruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840520A (en) *	1989-08-28	1998-11-24	Aviron	Recombinant negative strand RNA virus expression systems
US5658772A (en)	1989-12-22	1997-08-19	E. I. Du Pont De Nemours And Company	Site-specific recombination of DNA in plant cells
US5919676A (en) *	1993-06-24	1999-07-06	Advec, Inc.	Adenoviral vector system comprising Cre-loxP recombination
EP0704533A1 (en) *	1994-09-30	1996-04-03	Bayer Ag	An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
AU3760495A (en) *	1994-09-30	1996-04-26	Aviron	Chimeric Influenza Virus And Electroporation Method
CN1200675A (zh) *	1995-10-20	1998-12-02	耶路撒冷希伯来语大学依苏姆研究开发公司	流感疫苗
US5994526A (en) *	1996-06-21	1999-11-30	Plant Genetic Systems	Gene expression in plants
EP1035209A1 (en) *	1999-03-06	2000-09-13	ARTEMIS Pharmaceuticals GmbH	Stable recombinant influenza viruses free of helper viruses
PT1820853E (pt) *	1999-04-06	2012-01-03	Wisconsin Alumni Res Found	Vírus recombinante da gripe para vacinas e terapia genética

2000
- 2000-04-05 PT PT07009953T patent/PT1820853E/pt unknown
- 2000-04-05 AU AU40733/00A patent/AU4073300A/en not_active Abandoned
- 2000-04-05 EP EP14200291.4A patent/EP2910629B1/en not_active Expired - Lifetime
- 2000-04-05 DK DK07009953.6T patent/DK1820853T3/da active
- 2000-04-05 AT AT00920151T patent/ATE368729T1/de active
- 2000-04-05 ES ES07009953T patent/ES2373405T3/es not_active Expired - Lifetime
- 2000-04-05 CN CN00807495XA patent/CN1350578B/zh not_active Expired - Lifetime
- 2000-04-05 EP EP00920151A patent/EP1185615B1/en not_active Expired - Lifetime
- 2000-04-05 DE DE122008000058C patent/DE122008000058I1/de active Pending
- 2000-04-05 PT PT00920151T patent/PT1185615E/pt unknown
- 2000-04-05 AT AT07009953T patent/ATE525461T1/de active
- 2000-04-05 DK DK00920151T patent/DK1185615T3/da active
- 2000-04-05 DE DE200812000014 patent/DE122008000014I1/de active Pending
- 2000-04-05 DE DE60035778T patent/DE60035778T2/de not_active Expired - Lifetime
- 2000-04-05 ES ES00920151T patent/ES2290024T3/es not_active Expired - Lifetime
- 2000-04-05 KR KR1020017012743A patent/KR100702275B1/ko not_active Expired - Lifetime
- 2000-04-05 CA CA2365526A patent/CA2365526C/en not_active Expired - Lifetime
- 2000-04-05 IL IL14570200A patent/IL145702A0/xx unknown
- 2000-04-05 EP EP10011896.7A patent/EP2345716B1/en not_active Expired - Lifetime
- 2000-04-05 ES ES10011896.7T patent/ES2533622T3/es not_active Expired - Lifetime
- 2000-04-05 DE DE122008000061C patent/DE122008000061I1/de active Pending
- 2000-04-05 MX MXPA01010082A patent/MXPA01010082A/es active IP Right Grant
- 2000-04-05 CN CN201010155623.8A patent/CN101851636B/zh not_active Expired - Lifetime
- 2000-04-05 DE DE122008000035C patent/DE122008000035I1/de active Pending
- 2000-04-05 BR BRPI0009580A patent/BRPI0009580B8/pt not_active IP Right Cessation
- 2000-04-05 DK DK10011896.7T patent/DK2345716T3/en active
- 2000-04-05 JP JP2000609542A patent/JP5543048B2/ja not_active Expired - Lifetime
- 2000-04-05 EP EP07009953A patent/EP1820853B1/en not_active Expired - Lifetime
- 2000-04-05 WO PCT/US2000/009021 patent/WO2000060050A2/en not_active Ceased
- 2000-04-05 CA CA2928263A patent/CA2928263A1/en not_active Abandoned
2001
- 2001-09-30 IL IL145702A patent/IL145702A/en not_active IP Right Cessation
2007
- 2007-10-08 CY CY20071101295T patent/CY1108520T1/el unknown
2008
- 2008-11-13 NL NL300364C patent/NL300364I2/nl unknown
- 2008-11-13 NL NL300365C patent/NL300365I2/nl unknown
2011
- 2011-04-21 JP JP2011095240A patent/JP5775351B2/ja not_active Expired - Lifetime
- 2011-07-26 FR FR11C0027C patent/FR11C0027I2/fr active Active
- 2011-07-26 DE DE201112100037 patent/DE122011100037I1/de active Pending
- 2011-12-12 CY CY20111101234T patent/CY1112140T1/el unknown
2015
- 2015-03-31 JP JP2015071406A patent/JP6224645B2/ja not_active Expired - Lifetime
2016
- 2016-02-25 HK HK16102164.8A patent/HK1214298A1/en unknown

Also Published As

Publication number	Publication date
CN1350578A (zh)	2002-05-22
DK1185615T3 (da)	2007-11-05
DE122011100037I1 (de)	2012-03-22
EP1185615A2 (en)	2002-03-13
HK1148778A1 (zh)	2011-09-16
NL300365I2 (nl)	2017-08-03
EP2910629B1 (en)	2018-09-19
CY1108520T1 (el)	2014-04-09
EP1820853B1 (en)	2011-09-21
WO2000060050A3 (en)	2001-01-18
ATE368729T1 (de)	2007-08-15
DE122008000014I1 (de)	2011-12-01
CA2928263A1 (en)	2000-10-12
FR11C0027I2 (fr)	2021-12-31
DE122008000035I1 (de)	2009-05-20
IL145702A (en)	2010-04-15
KR100702275B1 (ko)	2007-03-30
EP1820853A2 (en)	2007-08-22
JP2015119735A (ja)	2015-07-02
ES2290024T3 (es)	2008-02-16
DE122008000061I1 (de)	2009-02-12
HK1214298A1 (en)	2016-07-22
BR0009580A (pt)	2002-01-02
BRPI0009580B8 (pt)	2021-05-25
CN101851636B (zh)	2015-11-25
ATE525461T1 (de)	2011-10-15
ES2533622T3 (es)	2015-04-13
JP2003528570A (ja)	2003-09-30
FR11C0027I1 (fr)	2011-08-26
EP1185615B1 (en)	2007-08-01
PT1820853E (pt)	2012-01-03
DK2345716T3 (en)	2015-02-09
ES2373405T3 (es)	2012-02-03
JP5543048B2 (ja)	2014-07-09
EP2345716B1 (en)	2015-01-14
JP5775351B2 (ja)	2015-09-09
JP6224645B2 (ja)	2017-11-01
IL145702A0 (en)	2002-07-25
CN101851636A (zh)	2010-10-06
PT1185615E (pt)	2007-10-04
BR0009580B1 (pt)	2014-11-25
DE60035778D1 (de)	2007-09-13
EP1820853A3 (en)	2007-10-03
CY1112140T1 (el)	2015-11-04
CA2365526A1 (en)	2000-10-12
DE60035778T2 (de)	2008-04-30
CA2365526C (en)	2016-07-05
KR20010113044A (ko)	2001-12-24
CN1350578B (zh)	2010-05-12
MXPA01010082A (es)	2002-04-24
DK1820853T3 (da)	2011-12-19
JP2011182797A (ja)	2011-09-22
EP2345716A1 (en)	2011-07-20
DE122008000058I1 (de)	2009-05-07
EP2910629A1 (en)	2015-08-26
NL300364I1 (nl)	2009-01-05
WO2000060050A2 (en)	2000-10-12
NL300364I2 (nl)	2017-08-03
AU4073300A (en)	2000-10-23

Publication	Publication Date	Title
NL300364I1 (nl)	2009-01-05	Recombinante influenzavirussen voor vaccins en gentherapie
MX342639B (es)	2016-10-07	Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica.
DK1021547T3 (da)	2007-04-23	Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
FR20C1016I1 (nl)	2020-06-12
PL398576A1 (pl)	2012-10-08	Preparaty szczepionek, preparaty farmaceutyczne, atenuowany wirus grypy, sposoby szczepienia, sposoby zapobiegania chorobie zakaznej, sposoby leczenia lub profilaktyki nowotworów, kompozycje szczepionek i kompozycje farmaceutyczne
EA200201279A1 (ru)	2003-06-26	Способы и композиции для лечения вирусного гепатита c
AU2002337083A1 (en)	2003-03-24	Vaccinia virus mva-e3l-knockout-mutants and use thereof
EP1159967A4 (en)	2002-07-10	TUMOR VACCINE
ATE458496T1 (de)	2010-03-15	Hiv-vakzine und anwendungsverfahren
DE69732029D1 (de)	2005-01-27	Dna enthaltende impfstoffen
CY1107560T1 (el)	2013-03-13	Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο